Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 29,500
-50 (-0.17%)
At close: Sep 11, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 244.18 billion as of September 11, 2026. Its market cap has decreased by -58.67% in one year.
Market Cap
244.18B
Enterprise Value
216.14B
Revenue
17.79B
Ranking
n/a
PE Ratio
1,049.96
Stock Price
29,500.00
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 244.18B, an increase of 28.66%. That is a compound annual growth rate of 13.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 244.18B | -66.71% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 185.88B |
| MEDIANA Co.,Ltd | 150.56B |
| L&K Biomed | 124.94B |
| Mezoo | 121.45B |
| Remed | 78.85B |
| Dynamic solution | 64.13B |
| Hironic | 63.44B |
| SELVAS Healthcare | 58.64B |